loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
cancer patients� lives are being put at risk because savage tory cuts to the nhs are delaying the start of their treatment by 18 months.
.
.
.
.
schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals."
.international